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ABSTRACT
The large collections of ChIP-seq data rapidly
accumulating in public data warehouses provide
genome-wide binding site maps for hundreds of tran-
scription factors (TFs). However, the extent of the
regulatory occupancy space in the human genome
has not yet been fully apprehended by integrating
public ChIP-seq data sets and combining it with
ENCODE TFs map. To enable genome-wide identi-
fication of regulatory elements we have collected,
analysed and retained 395 available ChIP-seq data
sets merged with ENCODE peaks covering a total
of 237 TFs. This enhanced repertoire complements
and refines current genome-wide occupancy maps
by increasing the human genome regulatory search
space by 14% compared to ENCODE alone, and also
increases the complexity of the regulatory dictio-
nary. As a direct application we used this unified
binding repertoire to annotate variant enhancer loci
(VELs) from H3K4me1 mark in two cancer cell lines
(MCF-7, CRC) and observed enrichments of specific
TFs involved in biological key functions to cancer
development and proliferation. Those enrichments of
TFs within VELs provide a direct annotation of non-
coding regions detected in cancer genomes. Finally,
full access to this catalogue is available online to-
gether with the TFs enrichment analysis tool (http:
//tagc.univ-mrs.fr/remap/).
INTRODUCTION
Differences in gene expression programs are believed to play
a major role in cell identity and phenotypic diversity in the
human body.With the advances of next generation sequenc-
ing techniques it became possible to study the genome-wide
occupancy maps of transcription factors (TFs) by chro-
matin immunoprecipitation followed by sequencing (ChIP-
seq). The rapid accumulation of ChIP-seq results in data
warehouses provides a unique resource of hundreds of oc-
cupancy maps.
With the success of the Encyclopedia of DNA elements
(ENCODE) project to identify all functional elements in the
human genome, the description and annotation of TF bind-
ing sites (TFBS) entered a genome-wide era by integrating
a hundred TFs. The extent to which the regulatory space is
organized along the genome is only starting to unfold with
large consortia studies (1–5) but remains largely matter of
discoveries (e.g. super enhancers) (6,7). Indeed, recent stud-
ies have uncovered hundreds of genomic loci that are co-
occupied by multiple TFs in various cell types suggesting
the importance and abundance of combinatorial regulation
in cells (2,7,8). So far, those diverse regulatory features gen-
erated from various studies have not been yet integrated to
form a global map of regulatory elements.
Here, we report the complex landscape of TFBS in the
human genome. We have constructed a global map of reg-
ulatory elements by compiling the genomic localization of
132 different TFs across 83 different cell lines and tissue
types based on 395 selected human public (non-ENCODE)
data sets. The integration of the genome-wide TFBS allows
for the construction of a catalogue of cis-regulatory mod-
ules (CRMs) of variable complexity.
Specifically, we report a complex map of TFBS increas-
ing by 14% (+439Mb, +993 421 regulatory features) the hu-
man genome regulatory search space compared to the EN-
CODE catalogue alone. Different studies have proposed to
integrate various NGS ChIP-seq data sets but either from
a workflow/platform approach (9) or from a quality assess-
ment perspective (10). We performed a detailed compari-
son of the TFs occupancy map generated from public data
against the ENCODE TF catalogue. Both maps are exam-
ined at the levels of TFs, TFBS and CRMs scales; finally,
both maps are merged allowing the creation of a large cat-
alogue of complex organization of bound regions. In to-
tal, after including ENCODE TF data to complement pub-
lic data, we examined 237 TFs across multiple cell types.
This map has been compiled into public tracks in genome
browsers allowing users to assess regulatory elements com-
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bined with genome annotations in their regions of interests.
In addition, the catalogue has been compiled into flat files
allowing further computational analyses and is available at
http://tagc.univ-mrs.fr/remap/.
Finally, to demonstrate the usefulness of our approach
we used this unified catalogue to annotate variant enhancer
loci (VELs; H3K4me1 mark) from two cancer cell lines.
Our TFs enrichment analyses within those variable regions
reveal enrichments of specific TFs those functions are in-
volved in cancer development and proliferation. The work
presented here constitutes a solid unification of regulatory
regions in the human genome using a systematic integra-
tion of public non-ENCODE and ENCODE data. Taken
together with our TF enrichment tool it allows for a better
annotation of enhancers.
MATERIALS AND METHODS
Public/non-ENCODE data sets sources
Public ChIP-seq data sets were extracted fromGeneExpres-
sion Omnibus (GEO) and ArrayExpress (AE) databases.
For GEO, the query ‘(‘chip seq’ OR ‘chipseq’ OR ‘chip se-
quencing’) AND ‘Genome binding/occupancy profiling by
high throughput sequencing’ AND ‘homo sapiens’[organism]
AND NOT ‘ENCODE’[project]’ was used to return a list
of all potential data sets to analyse, which were then manu-
ally assessed for further analyses. Data sets involving poly-
merases (i.e. Pol2 and Pol3), mutated or fused TFs (e.g.
KAP1 N/C terminal mutation, GSE27929) and p300/CBP
TFs were excluded.
A data set was defined as a ChIP-seq experiment in a
given GEO series (e.g. GSE41561), for a given TF (e.g.:
ESR1), in a particular biological condition (e.g. MCF-7).
Data sets were labelled with the concatenation of these three
pieces of information (e.g. GSE41561.ESR1.MCF-7).
We analysed 668 data sets present in the GEO repository
starting from July 2008. Those data sets were complemented
by 28 data sets present in AE. (Full list of data sets in Sup-
plementary File S1).
Public ChIP-seq processing
Bowtie 2 (11) with options –end-to-end –sensitive was used
to align all reads on the human genome (GRCh37/hg19 as-
sembly). Biological and technical replicates for each unique
combination of GSE/TF/Cell type or Biological condition
were combined after mapping. TFBS were identified using
MACS peak-calling tool (12) (version 1.4.1) in order to fol-
low ENCODE ChIP-seq guidelines, with stringent thresh-
olds (P-value: 1e-5; enrichment: 10; False discovery rate,
FDR: 0.01). An input data set was used when available.
Because of the large size of peaks sometimes identified by
MACS (up to 62 kb; mean size: 505.2 bp, median size: 377
bp), we used the tool PeakSplitter (13) (version 0.1) to re-
trieve shorter peaks (up to 4.7 kb; mean size: 350.9 bp, me-
dian size: 304) containing summits.
ENCODE data sets
We used the ENCODE release V3 (August 2013) rep-
resenting all ENCODE TF ChIP-seq experiments
passing quality assessments. This data provides TFBS
clustered by factor, based on 690 data sets and 161
TFs (http://hgdownload.cse.ucsc.edu/goldenPath/
hg19/encodeDCC/wgEncodeRegTfbsClustered/
wgEncodeRegTfbsClusteredV3.bed.gz). We removed
3 TFs (POLR2A, POLR3G, EP300), and renamed 3
TF aliases into official HGNC identifiers (GRp20 into
NR3C1, KAP1 into TRIM28, SIN3AK20 into SIN3A)
leading to a final list of 155 TFs from ENCODE.
Quality assessment of public data sets
To assess the quality of public data sets, we computed a
score based on the cross-correlation and the FRiP (frac-
tion of reads in peaks) metrics developed by the ENCODE
Consortium (14) (Supplementary Figure S2). Two thresh-
olds were defined for each of the two cross-correlation ratios
(NSC, normalized strand coefficient: 1.05 and 1.10; RSC,
relative strand coefficient: 0.8 and 1.0). Detailed descrip-
tions of the ENCODE quality coefficients can be found
at http://genome.ucsc.edu/ENCODE/qualityMetrics.html.
We used the phantompeak tools suite (15) (https://code.
google.com/p/phantompeakqualtools/) to compute RSC
and NSC. The selected cut-off minimum and optimum val-
ues for the two ratios are defined in phantompeak tools.
NSC values range from a minimum of 1 to larger positive
numbers. Note that 1.10 is the critical threshold. Data sets
with NSC values much less than 1.10 (<1.05) tend to have
low signal-to-noise ratio or few peaks. RSC values range
from 0 to larger positive values. Note that 1 is the critical
threshold. RSC values much less than 1 (<0.8) tend to have
low signal-to-noise ratio, the low scores can be due to failed
and poor quality ChIP and/or low read sequence quality.
A basal score ranging from 0 to 4 was assigned to each
data set corresponding to the number of thresholds it ex-
ceeds for NSC and RSC (two thresholds for each score).
This basal score was incremented by one if the FRiP is equal
or higher than 1%.We observed that data sets having amin-
imum score of 2 exceeded at least one threshold of RSC
or NSC, which are both scores independent of peak call-
ing procedures. Thus, data sets with a final score less than
or equal to 1, as well as data sets with fewer than 100 iden-
tified peaks were discarded for further downstream analy-
ses. Those data sets were not included in the final catalogue
of public peaks available on our resource page (ReMap:
http://tagc.univ-mrs.fr/remap/).
Non-redundant sets of peaks and CRMs definition
To produce a catalogue of discrete, non-redundant binding
regions in the genome for each TF, we used BedTools (16)
(version 2.17.0) to merge overlapping peaks (with at least 1
bp overlap) identified in different data sets for similar TFs.
Public and ENCODE binding sites were combined before
the overlap. The summit of resulting peaks was defined as
the average position of the summits of merged peaks. Simi-
larly, to obtain the CRMs in the genome, overlapping peaks
of all TFs in the catalogue were merged using BedTools. Re-
gions bound by several TFs are called CRMs, whereas re-
gions bound by only one TF are labelled as singletons.
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Genomic localization
To localize regulatory regions (Peaks and CRMs) in the
genome, we used CEAS (17) (version 0.9.9.7). Each re-
gion was assigned to a genomic localization such as in-
tergenic, intronic, exonic, 5′- or 3′-UTR or promoter (−3
kb upstream to TSS) based on human RefSeq annotation
(GRCh37/hg19). Repartition of CRMs around TSSs was
analysed after extraction of the TSSs from Ensembl genes
(Ensembl release v67).
Comparison with genomic resources
Public sets of genes, protein coding genes and regulatory
elements (Vista enhancers and ORegAnno) were down-
loaded from the Ensembl genome portal (Ensembl release
v67) using BioMart and from the UCSC table browser
tool (hg19 assembly). Promoters were defined as −2
kb/+1 kb from transcription start sites (TSS). ENCODE
DNaseI clusters (V2, January 2013) were downloaded from
UCSC (http://hgdownload.cse.ucsc.edu/goldenPath/
hg19/encodeDCC/wgEncodeRegDnaseClustered/
wgEncodeRegDnaseClusteredV2.bed.gz). We employed
BedTools for overlap analyses allowing 1 bp overlap.
Motif discovery
The RSAT (Regulatory Sequence Analysis Tools) suite was
used for de novo motifs analyses in non-redundant binding
sites of each TF. The RSAT program peak-motifs (18) with
the options --markov auto –minol 6 –maxol 8 –merge lengths
–2str –scan markov 3 was run to detect overrepresented
words and dyads, which were then compared against known
motifs from JASPAR core vertebrates database (version
November 2013). ENCODE motifs were extracted from
FactorBook (19), and JASPAR motifs from the JASPAR
core vertebrates database (20) (version 5.0 alpha).
Conservation scores
For each of the 237TFs present in our cataloguewe assessed
the DNA constraint for each base pairs 1 kb around the
summit of each peak. Conservation scores were obtained
from the Ensembl Compara database (21) release v67. Ge-
nomic Evolutionary Rate Profiling (GERP; (22)) score was
used to calculate the conservation of each nucleotide in
multi-species alignment. The multiple whole genome align-
ment used to derive GERP score is the 20-way amniota ver-
tebrates Enredo-Pecan-Ortheus (EPO) alignment.
Network analyses
The overlap of non-redundant binding sites for each cou-
ple of TFs was computed using IntervalStats tool (version
1.01) (23). For each peak in the query set of binding sites,
IntervalStats computes aP-value of the overlap of this peak
with the reference set of binding sites. A P-value threshold
was defined as 0.05 to identify significant overlapping peaks
with the reference. Each TF was used both as query and as
reference in each couple of TFs, forming an asymmetricma-
trix of the percentages of significant overlapping peaks be-
tween two TFs (Supplementary Figure S7). For each TF,
a list of strongly and moderately specific TFs was deter-
mined by identifying outliers based on the percentages of
significant overlapping peaks. Outliers were defined as TFs
that have a percentage exceeding 1.5 and 3.0, respectively,
for moderately and strongly specific TFs, the interquartile
range above the 75th percentile of percentages (Supplemen-
tary Figure S8). A network was generated using Gephi tool
(24) (version 0.8.2) with all TFs that co-localized with at
least one other TF. The size of nodes is correlated with the
number of interactors (i.e. co-localized TFs) for each TF.
The weight of edges corresponds to strong (thick line) or
moderate (thin line) specificity of the co-localization of TFs,
and colour represents the percentages of significant overlap-
ping peaks between the two TFs. The graph was partitioned
into subnetworks using an algorithm developed by Blondel
et al. (25) and implemented in Gephi, with options random-
ize, use edge weights and a resolution of 0.51.
VELs
Two sets of VELs were analysed in this study, from CRC
(colorectal cancer) and MCF-7 (breast cancer) cell lines.
First, the list of CRC gained and lost VELs described
in Akhtar-Zaidi et al. (26) were downloaded from GEO
(GSE36204). For downstream analyses hg18 VELs were
converted into hg19 coordinates using the liftover tool
of UCSC (http://genome.ucsc.edu/cgi-bin/hgLiftOver) with
default parameters returning 2604 gained and 3448 lost
CRC VELs.
On the other hand, to create theMCF-7 VELs we applied
the same procedures as described in thematerials andmeth-
ods of Akhtar-Zaidi et al. on H3K4me1 of MCF-7/MCF-
10A data sets produced by Choe et al. (27). Sequencing
data were downloaded from the Sequence Read Archive
(SRA045635) of the National Center for Biotechnology In-
formation. Read alignments, peaks calls and VEL detection
were all performed using the exact same procedure as de-
scribed in Akhtar-Zaidi et al. We obtained a set of 3163
gained and 2791 lostMCF-7 VELs using a normal distribu-
tion with a standard deviation of 1 to model the uniformly
distribution of reads. To assess the MCF-7 VELs detection
procedure we also generated VELs with relaxed thresholds
(SD = 0.75, 5295 for Gained, 5087 for Lost) and report
those result in Supplementary Figure S9. IntervalStats tool
was used to compute and identify significant overlapping
TFBS with VELs. TF enrichments in VELs were calculated
via a hypergeometric test.
We have extracted RNA-seq data for MCF-7 and MCF-
10A cell lines, respectively, from GEO (GSE48213). We
compared gene expression (FPKM, fragments per kilobase
per million mapped reads) of genes associated with gained,
lost and control VEL. Genes were associated with VEL re-
gions using the GREAT tool (great.stanford.edu). Control
loci are H3K4me1 loci identified in common between the
MCF-7 and MCF-10A cell lines.
Public access and annotation tool
Our catalogues of public peaks and public + ENCODE
peaks are publically available either as a track in the UCSC
genome browser and also with extra analyses at http://tagc.
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univ-mrs.fr/remap/. An annotation tool has been deployed,
available on the website, allowing user to query their regions
of interests against our catalogue of TFBS to identify en-
richments of TFs. The entire catalogues are also available
to download.
RESULTS
Our overall approach is to analyse ChIP-seq data sets for
TFs from public repositories in order to provide a compre-
hensive map of regulatory elements. To do this we first ex-
tracted and processed all available public data sets, which
were merged with the ENCODE TF catalogue to produce
an extensive repertoire of regulatory regions in the human
genome (Flowchart Supplementary Figure S1). We then
used this regulatory catalogue to identify genome-wide co-
localized TFs and TFs enriched in VEL present in colon
cancer and breast cancer cell lines. We further present an
online tool providing a full web access to this catalogue and
allow users to annotate their genomic regions with regula-
tory elements.
Integration of various ChIP-seq data sources
We initially selected 696 data sets from public repositories,
such as the GEO (28) and AE (29). To ensure consistency
and comparability, each of these ChIP-seq data sets was re-
analysed from the raw reads, through our ChIP-seq anal-
ysis pipeline which included read mapping, peak calling
and quality assessment based on ENCODE quality criteri-
ons. Those quality criterions determined whether a data set
would be included or not for further downstream analyses
or excluded. Indeed, ChIP-seq data sets are not all equal in
terms of quality (10), these differences come from the rapid
development of next-generation sequencers and sequencing
techniques, but also from experimental improvements in li-
brary preparations and quality.
To address this variability of ChIP-seq quality we used
two metrics independent of peak calling based on EN-
CODE ChIP-seq guidelines and practices. First, we used
the normalized strand cross-correlation coefficient (NSC)
which is a ratio between themaximal fragment-length cross-
correlation value and the background cross-correlation
value, and the relative strand cross-correlation coeffi-
cient (RSC), a ratio between the fragment-length cross-
correlation and the read-length cross-correlation (14). Both
values are stringent metrics for assessing signal-to-noise ra-
tios in a ChIP-seq experiment and have been correlated
with high quality data sets (Encode guidelines (14)). Those
ChIP-seq quality analyses are in accordance with current
assessments of disparate published ChIP-seq data sets (10).
However, on top of those scores based on alignments qual-
ity we added two metrics based on peak properties: the
FRiP and a useful but simple first-cut metric, the number of
peaks in the data set. By using these four scores we were able
to evaluate ChIP-seq data and filter out low quality data sets
(Supplementary Figure S2).
We initially collected, analysed and assessed 696 raw TF
ChIP-seq data files in various conditions from Illumina se-
quencers and available in public data warehouses (GEO,
AE). After applying our quality filters based on these four
ChIP-seq metrics we retained 395 data sets (54.3%) from
135 different GEO series (GSEs) involving 132 TFs (Sup-
plementary Table S1). More precisely, we define here a
‘data set’ as a ChIP-seq experiment in a given GEO series
(e.g. GSE41561), for a given TF (e.g. ESR1), in a partic-
ular biological condition (i.e. cell line, tissue type, disease
state or experimental conditions; e.g. MCF-7). Data sets
were labelled with the concatenation of these three pieces
of information (e.g. GSE41561.ESR1.MCF-7). A data set
may correspond to several replicates when multiple samples
were done in the same GEO series, for the same TF under
identical biological conditions. TFBS were computed fol-
lowing our peak-calling pipeline using MACS tool as de-
scribed in detail in themethod section.We identified 8.9mil-
lion ChIP-seq peaks bound by TFs in the human genome
across all data sets. The complete data sets (mapped reads
and called peaks) are available from our online companion
(http://tagc.univ-mrs.fr/remap/).
Binding sites for similar TFs but produced from differ-
ent data sets mapped onto the genome revealing tight and
dense co-localization of sites in many regions of the genome
(Figure 1A). This clustering of binding sites from differ-
ent data sets is illustrated as an example within the first in-
tron of SMAD4 and ELAC1 genes by a FOXA1 site reca-
pitulated by 14 data sets. Those data sets correspond to 7
different GEO series (GSE), 4 different cell lines (MCF-7,
ZR-75-1, LNCaP, C4-2B), 4 different institutes (the Cancer
Research UK Cambridge Institute, the Genomic Institute
of Singapore, the University of Helsinki, the Washington
University School of Medicine) and finally 3 different anti-
bodies (Abcam ab5089, ab23738, ab4124). Interestingly, it
can be noted that the summits (vertical bars) of the peaks
aggregate closely from each other. Those aggregations of
FOXA1 summits are an illustration of what is globally ob-
served acrossmillions of peaks on the genome. This FOXA1
example is a simple demonstration that global integrative
analyses of ChIP-seq data sets can improve the detection
of TFBS. Indeed, the presence of a binding site in different
data sets at this position for FOXA1 reinforces the possibil-
ity that this specific TF is binding the DNA in vivo at this
genomic location.
To further investigate whether our re-analysed public
data sets correlated with each other we generated a corre-
lation matrix based on the genomic localization of peaks
(Figure 1B). The 395 data sets were clustered on the ba-
sis of co-binding correlations. Heatmap colours correspond
to Pearson’s correlation coefficients of low (blue) to high
(red) range of co-binding affinity. Consistently, we observe
that data sets are generally clustered by similar TFs, or
similar cell lines. Several dense clusters with high bind-
ing co-occurrences are detected within this correlation ma-
trix. The most striking clusters of TFs with highly cor-
related binding profiles are clusters regrouping most of
p53, NANOG/POU5F1, ESR1, TFAP2C, MYC/MAX
and CTCF. Some of those clusters tend to be also enriched
in specific cell lines LNCaP and MCF-7 (Figure 1C). The
ESR1 cluster regroups 8 out 10 GEO series and consists
mainly of the MCF-7 cell type with different experimen-
tal conditions. It can be noted that the CTCF insulator
forms a tight cluster containing all the CTCF data sets in
this analysis (Figure 1B, orange). This indicates that most
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Figure 1. ChIP-seq binding pattern of 395 data sets. (A) A genome browser example of complex ChIP-seq binding patterns of the 395 data sets at the
SMAD4/ELAC1 promoters, and a detailed view of the redundant peaks for a FOXA1 site. The following genome tracks correspond to the ChIP-seq peak
summits (black vertical lines), the 100 vertebrates conservation track from UCSC and the condensed ENCODE TF bindings. (B) Co-binding correlation
patterns of the 395 data sets are clustered and shown as a heatmap with blue to red indicating low to high correlations for each co-localized data sets.
Co-binding relationships between TFs and cell types across all data sets are observable. Co-localization clusters are highlighted with coloured bars and
(C) some clustered data sets are shown in details (e.g. ESR1 in MCF-7 cells).
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CTCF bindings are shared across all different ChIP-seq ex-
periments regardless of the cell types. This result comple-
ments current findings about CTCF (30,31) where there is
little difference of CTCF binding between cell types (3).
Taken together these clusters indicate that a consistent ana-
lytic approach of multiple data sets can recapitulate binding
sites and reveal that some TFs bind similar locations in the
genome. Although the integration of independent ChIP-seq
studies is challenging, the overlap observed between peaks
for similar TF validate this approach in order to improve
the annotation of regulatory regions in the human genome.
Identifying and dissecting CRMs
Our initial catalogue of 8.9 million binding sites identi-
fied across all data sets includes overlapping sites bound by
similar TFs immunoprecipitated in various conditions and
therefore do not reflect the total number of discrete bind-
ing regions across the genome. To address this redundancy
between data sets we merged binding sites of similar TFs,
resulting in a catalogue of 5.4 million sites which we define
as non-redundant peaks (Figure 2A). As non-redundant
peaks are made of at least two or more peaks for a given
factor, we addressed whether our method would modify the
summit location for those non-redundant peaks. We ob-
serve a mean variation of 37 bp between the summits of
the non-redundant peaks set and the individual summits of
peaks they are made of (Supplementary Figure S3). These
narrow summit variations across peaks of similar TF jus-
tify the use of a method to merge them into non-redundant
peaks. The genomic organization of our occupancy map re-
veals dense co-localizations of sites forming tight clusters
of heterogeneous binding sites with variable TFs complex-
ity (Figure 1A). Those clustering patterns of TFBS along
the genome were defined as CRMs by merging overlapping
peaks into 666 594 CRMs. Among our catalogue of 5.4 mil-
lion non-redundant TFBS, 84% can be incorporated into
CRMs. About half of CRMs contains 2 or 3 TFs and span a
few hundred base pairs, whereas the other half corresponds
to regions binding multiple TFs creating complex regula-
tory elements spanning few kilobases (Figure 2B). For ex-
ample, out of our CRMs set 8.4% is composed of complex
combination of TFs containing 15 or more TFs (Figures
1A, 2B and 3B). These highly complex CRMs are mainly
found in promoters and around TSSs reminding previously
defined highly occupancy targets regions frequently asso-
ciated with promoters (32,33). Our large TFBS catalogue
leads to 666 594 regulatory sequence elements where about
50% form complex CRMs.
Since single TFBS have been shown to positively corre-
late with gene density across the genome (34), we exam-
ined the relationship between CRM complexity and their
genomic localization (Figure 2C and D). We observe that
half of singletons and small CRMs fall within gene bodies
and in close gene proximity (Promoters, UTRs). However,
as CRMs complexity increases, their localization shows a
clear preference for promoters. The enrichment of CRMs
at proximal promoters is consistent with previous findings
(35). However, as CRMs complexity increases the proximal
promoters preferential occupancy is done in detriment to
intergenic/distal regions. Interestingly, we observe that on
average 2%of Singletons andCRMs are localizedwithin ex-
ons which support the possible role ofDNAbinding protein
on restricting transcripts diversity (5). Here, we show that
proximal promoters can potentially act as platforms of ex-
tremely complex and dense TF bindings. To further address
this we also investigated the TF bindings around the TSSs
(±2.5 kb) (Figure 2D). We observe a positive relationship
between dense binding and TSS with complex CRMs pref-
erentially positioned at TSS. Taken together those results in-
dicate that core promoters can potentially attract a large set
of transcriptions factors and co-factors. Interestingly, it also
highlights the presence of intergenic CRMs attracting 10–
30 TFs possibly acting as distal or remote enhancers. These
results agreewith findingswhere distal enhancers are associ-
ated with active chromatin marks in a cell-type-specific way
(31), whereas promoters tend to be constitutively occupied
in multiple cell lines.
To determine the accuracy of our enhancer catalogue we
next identified the fraction of major genomic resources of
known elements that are covered by our data. We first anal-
ysed genome-wide set of regions that are likely to be in-
volved in gene regulation, such as accessible chromatin and
regulatory resources.We recovered 70%of ENCODEDNa-
seI hypersensitive sites (50% CRMs only), 80% of Ensembl
regulatory build based, 78% of Vista Enhancers and 95% of
ORegAnno annotations. In addition to regulatory regions,
we also compared our catalogue with various sources of an-
notated promoters. We recovered 90% of UCSC promoters
and 85% of Ensembl promoters. Finally, we compared our
catalogue with human gene build from three major gene an-
notation resources: UCSC, Ensembl and RefSeq.We recov-
ered 90%ofUCSC genes, 90%of Ensembl coding genes and
70% of all Ensembl genes. The 10–30% of genes not recov-
ered by our catalogue are in majority non-coding genes and
pseudo-genes, either not bound by TFs or bound by TFs
not yet present in our catalogue (Supplementary Table S2).
As previously shown a large fraction of annotated genes are
recovered as 40% of our catalogue fall within gene bodies
mainly introns, but also exons and UTRs (Figure 2C). The
above evidences indicate that our catalogue correctly iden-
tifies most known annotated genomic elements and anno-
tated enhancers from major public resources.
To test whether this catalogue of TFBS could consoli-
date DNA motifs found in current databases or provide
alternative/variable motifs we performed de novomotif dis-
covery (Figure 2F).When available we examined Jaspar (36)
and FactorBook/ENCODE (19) DNA motifs for a given
TF and compared those with our top motifs discovered
by RSAT peak-motifs tool (18). An example for the CTCF
DNA logo is shown in Figure 2F where subtle bases varia-
tions can be observed as well as consolidation of unchanged
bases in the motif. It is well established that ChIP-seq pro-
vide an excellent way to perform de novo motif analyses as
DNA motifs are enriched around peaks summits helping
the detection of the DNAmotifs for those TFs (14,37). Our
catalogue of TFBS can contribute to refine or consolidate
TF DNA matrices currently present in motif databases.
It has been shown that DNAmotifs are highly conserved
across species (37) thus the DNA sequence are under a
selective pressure. We thus examined for each TF the se-
quence conservation around all non-redundant peaks. This
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Figure 2. ChIP-seq peaks and CRMs. (A) A schematic diagram of the three types of regulatory regions: all peaks, non-redundant peaks and CRMs. Peaks
for similar TFs overlapping the same regions were merged into single peaks defined as non-redundant. For each genomic region bound by at least two
different TFs, those bindings were regrouped into CRMs. (B) Proportion of single and combined binding sites observed after identification of CRMs. The
vertical barplot correspond to proportion of CRMs found in combinatorial binding categories across all identified CRMs. (C) Genomic distribution of
single or combined binding sites in six different genomic regions. The percentage of binding sites in each category is shown on the vertical axis, for the
overall genome, singletons and each combinatorial binding complexity from 2 to 50+ TFs. (D) Distribution of CRMs at TSS (±2.5 kb) for increasing
levels of combinatorial binding complexity from 2 to 50+ TFs. (E) Proportion of our regulatory catalogue covering different types of genomic features.
Percentages of elements recovered are shown for CRMs only (green) and both CRMs and singletons (blue). (F) The WebLogo position weight matrix
diagrams for CTCF identified across the diverse databases, showing subtle position-specific differences. (G) DNA sequence constraint around the peak
summits of FOXA1, CTCF, CEBPA, NFYB were plotted by observed-expected GERP scores (22).
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analysis used the GERP differential scores where expected
and observed scores refer to the number of expected and
observed substitutions in the sequences (weighted by the
branch lengths of the tree). For four selected TFs (FOXA1,
CTCF, CEBPA, NFYB) we observe an increase of DNA
constraints under the summit positions of the ChIP-seq
peaks among the vertebrate species (Figure 2G). Interest-
ingly, NFYB DNA constraints describe a trimodal distri-
bution possibly as a result of the nature of the nuclear TF Y
forming a trimeric complex (with NFYA and NFYC) bind-
ing to the DNA with high specificity and affinity. Those
DNA constraints observations can be observed globally on
the genome browser with 100 vertebrate phastcons conser-
vation track (Figures 1A and 3B). Taken together those
analyses show that we have correctly identifiedmost binding
sites coming from public sources, that those sites regroup
into 666 594CRMs of various complexities and are possibly
identifying new regulatory regions in the human genome.
Complementing ENCODE TFBS data set
To address whether this catalogue would identify new regu-
latory regions within the genome, we analysed our data by
comparing our results with the reference annotation of reg-
ulatory regions in the human genome, the latest ENCODE
catalogue of DNA elements (4). The ENCODE catalogue
consists of 155 TFs that allowed the community to gain
a better understanding in the annotation of regulatory re-
gions in the human genome. We first assessed whether both
catalogues would overlap or complement each other. We
observe that ENCODE regulatory elements overlap by 89%
the public catalogue, but only 57% of the public regulatory
elements overlap with ENCODE (Figure 3A). This suggests
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that our catalogue based on public ChIP-seq data is comple-
mentary to ENCODE regions, and that the number of reg-
ulatory regions in the human genome may be greater than
anticipated. This overlap of ENCODE versus public reg-
ulatory elements is illustrated as a genome browser track
on Figure 3B, where we observe ENCODE TFBS comple-
menting public CRMs. When comparing those two cata-
logues, only 50 TFs are found in common between the two
studies, 105 TFs are specific to ENCODE and 82 TFs are
specific to the public catalogue (Figure 3C). We also found
that 272 132 CRMs are in common in both catalogues.
To improve the accuracy of our catalogue and to com-
plement the annotation of TF bound elements in the hu-
man genome we merged both ENCODE TFBS set and the
public catalogue leading to a large repertoire of 8.8 million
TFBS generated from 237 TFs (Figure 2A). This allowed
the generation of 802 508 CRMs with complex modules
binding 50 or more TFs. The number of CRMs contain-
ing 15 TFs or more increases from 8.4% using public data
only to 13.9% when merging both catalogues. Looking at
their genomic localization we observe that complex CRMs
concentrate at promoters in detriment to intergenic regions,
agreeing previous findings where enhancers tend to be cell-
type specific, and promoters constitutively bound (Figure
3D). Also by merging both catalogues we observe that the
human genome regulatory search space is increased by 14%
(+439 Mb) when comparing with the ENCODE genomic
coverage only.
Finally, to address whether the regulatory regions de-
tected in the human genome would reach a plateau we com-
puted CRMs based on the random selection of increasing
number of TFs (100× ranging from 2 to 237 TFs) (Figure
3E).We observe that the number ofCRMs is not finite in the
genome, as the computation of CRMs from randompermu-
tations of TFs does not reach a plateau. Each additional TF
continued to show additional CRMs rather reaching sat-
uration of regulatory regions in the genome. As our cat-
alogue contains diverse cell types, our result suggests that
many cell-specific binding sites potentially exist in diverse
cell types. Those conclusions are consistent with results ob-
tained by ENCODE for TFs across different cell lines (38),
with open chromatin elements defined by FAIRE andDNa-
seI (4), and with the 8 millions of TF sites as described by
DNAseI footprinting (5).
Cooperating TFs network
In a specific cellular context, genes are regulated by several
TFs that cooperate to increase or decrease the gene expres-
sion as demonstrated in recent work (4,39–42). This is es-
pecially the case for tissue-specific genes involving regula-
tory elements that bind cocktails of specific TFs. To iden-
tify these specific combinations of TFs, we generated a co-
localization network based on the overlap of binding sites
observed in our catalogue. We used IntervalStats tool to
compute significant overlaps between binding sites of each
pair of TFs and to calculate the percentage of overlapping
sites between factors. Based on this percentage we identified
strong and moderate co-localization specificity of TFs (see
Materials and Methods section). Gephi tool was used to
create and visualize the network containing 181 co-localized
TFs (Figure 4A). In this network, the weight of the edges
represents how specifically two TFs are associated together,
whereas the colour indicates their percentage of overlap-
ping binding sites. Although the network reveals that all
TFs are globally highly interconnected, we can distinguish
clusters of strongly specific TFs. To highlight these clusters
of TFs, we partitioned the network into 12 subnetworks
in different colours (Figure 4B and Supplementary Figure
S4) using an algorithm developed by Blondel et al. and im-
plemented in Gephi. To further understand the biological
role of these groups of TFs, we annotated them using the
DAVID online tool (Figure 4B). The first subnetwork (Fig-
ure 4B, yellow subnetwork) is annotatedwith embryonic de-
velopment terms as it contains the POU5F1 (Oct4), SOX2
and NANOG TFs. The second TFs subnetwork (green) re-
veals affinities with lung development functions. It contains
FOXA1 and FOXA2 both being co-expressed in respira-
tory epithelial cells throughout lung morphogenesis (27),
as well as SP1 those expression regulates lung tumour pro-
gression (28). Finally, a TFs cooperation subnetwork (or-
ange) is functionally enriched in hormone receptor anno-
tations as it contains factors, such as AR, ESR1, NR3C1
and NR3C3. Here, we show that using our global occu-
pancy map of 237 TFs we can highlight groups of coop-
erating TFs having specific functional enrichments. Find-
ing functional annotations for groups of TFs is a challeng-
ing task as all proteins are associated with Gene Ontology
terms, such as TF or DNA binding domain. However, the
TFs subnetworks identified based on co-localization data
only reveal relevant biological signatures. It can be noted
that our co-localization network show a global interplay of
TFs across the genome, however, the extent to which some
TFs act as master regulators is yet to be discovered. Some
studies started to describe how TFs could be ubiquitous or
tissue/function specific (43) but the complexity of TF inter-
play is yet to be unfolded.
Application to VEL in cancer
As a direct application of our catalogue we examined the
binding of TFs within gained and lost enhancer loci in pri-
mary CRC cell lines relative to normal colon epithelium
crypts as published by Akhtar-Zaidi (26). We applied the
same strategy to identify VELs from H3K4me1 mark in
human breast cancer cell line (MCF-7) relative to normal
mammary epithelial cell line (MCF-10A). Using sets of
gained and lost enhancers in both cancers we asked whether
those enhancers would enrich for specific TFBS biologically
related to these cancers. First, we observed that 95–98% of
VELs contained one or more TFBS (Supplementary Table
S3) with a clear positioning of binding sites at the center of
those loci (Figure 5A and B and Supplementary Figure S5).
When crossing our TF occupancy catalogue against those
loci, we identified enrichments of very specific TFs present
in gained or lost VELs, respectively.
For breast cancer, we report enrichment for ESR1 DNA
bindings in gained enhancer loci in MCF-7 cell line relative
to MCF-10A cell line (Figure 5C), as well as NR2F2 which
encodes a member of the steroid thyroid hormone recep-
tor, involved in apoptosis and increased proliferation (44).
Both of those TFs have been actively studied for their role in
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Figure 4. Network representations of TFs co-localization across the genome. (A) In this filtered TF co-localization network, nodes indicate individual
TFs and colours indicate subnetworks identified by applying a partitioning algorithm; edge colours depict the percentages of overlap between TFBS and
weights the co-localization specificity between two TFs. Overlapping binding sites were computed using IntervalStats tool and co-localization specificity
was determined by identifying outliers based on the percentages of significant overlapping sites. (B) Highlighted subnetworks of highly connected and
strongly specific TFs with functional annotations. Barplots represent Gene Ontology Biological Process enrichments calculated by DAVID (x-axis =
−log10 Benjamini score).
breast cancers development. Our analysis allows for the se-
lection of potential enhancers/target-genes couples poten-
tially involved in pathological processes leading to breast
cancer. We observe an enrichment of FOS and JUN present
in lost VELs,meaning that the binding of those twoTFs can
lead to anAP-1 complex loss inMCF-7 enhancers. The AP-
1 complex controls a number of cellular processes includ-
ing differentiation, proliferation and apoptosis. This loss of
DNAbinding inMCF-7 enhancers could indeed deregulate
normal cellular processes.
Regarding colorectal VELs, we find TP63 to be highly en-
riched within lost VELs (Figure 5D), it is a member of p53
family of TFs and has been shown to suppress tumorigene-
sis and metastasis (45). Interestingly, SUZ12 and EZH2 are
enriched in lost VELs. SUZ12 is part of the polycomb group
(PcG) family of proteins forming a complex with EZH2.
The PcG is thought to play a role in the epigenetic repres-
sion systems. Those proteins are involved in maintaining
the transcriptional repressive state of genes, leading to tran-
scriptional repression of the affected target gene. The loss
of DNA bindings for TP63, SUZ12 and EZH2 in those en-
hancers could activate genes involved in tumorigenesis and
metastasis. Interestingly, DCP1A also know as TF SMIF
is the most enriched TF in this group, its protein is ex-
pressed themost in colonRKO cancer cells according to the
MaxQuant database (46). For gained VELs in colon can-
cer we observe an enrichment of TCF7L2, also known as
TCF4, involved inmany cancer types (47). A frameshift mu-
tation of TCF7L2 has been shown to be implicated in CRC
(48). Interestingly, FOS and JUN are present in gained en-
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Figure 5. Specific TFs signature in VELs. (A) UCSC browser views of H3K4me1 profile of a normal mammary epithelial cell line (MCF-10A) and a breast
cancer cell line (MCF-7), illustrating an example of a gained (left in red) and a lost (right in blue) VELs. (B) Similar view of H3K4me1 profile for a primary
CRC (CRC V400) and a normal colon epithelium crypt (C104). (C) TFs specifically enriched within regions defined as gained or lost VELs in MCF-7 and
CRC (D) cell lines.
hancers in colon cancer, leading to implication in the differ-
entiation, proliferation and apoptosis of colon cancer cells.
Furthermore, the enrichment of STAT3 binding provides
further evidence of regulation of cell growth and apopto-
sis. The different TF enrichments found for FOS and JUN
within MCF-7 and CRC cell lines can be explained by the
different biological context, but also by the fact that differ-
ent combinations of AP-1 dimers can regulate a breadth of
cellular events (49).
Taken together the observed enrichments of TFs within
VELs in CRC and MCF-7 are involved in key processes,
such as differentiation, proliferation or apoptosis, a clear
signature of cancer. Their presence in either gained or lost
enhancers provides a clue whether those processes are ac-
tivated or repressed. Indeed, we support previously pub-
lished evidence of gene expression changes associated with
VELs (26). By analysing RNA-seq gene expression data in
MCF-7/MCF-10A we observe up-regulated genes associ-
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ated with gained VELs and down-regulated genes with lost
VELs (Supplementary Figure S6). OurH3K4me1 enhancer
analysis in cancers coupled with our regulatory catalogue
allow the fine dissection of potential key regulatory players
and regions in those cancers.
A web resource for exploring the TFBS catalogue and anno-
tating regions
The results presented here provide an informative annota-
tion for 13 million TFBS coming from public sources and
ENCODE data, which include in total 237 TFs across 83
diverse cell lines. This catalogue is a great source of infor-
mation for dissecting site-specific TF bindings (e.g. FOXA1
in Figure 1A) or for genome-wide binding analyses. To fa-
cilitate the exploration of the regulatory elements by the
scientific community, we created an online resource called
ReMap (http://tagc.univ-mrs.fr/remap/) to display informa-
tion about TFs (description, classification, external refer-
ences), peaks and data sets (quality assessment, read map-
ping and peak calling statistics, conservation score under
the peaks). This web resource enables data (full catalogue
of TFBS and binding sites for specific TFs) to be down-
loaded in BED or FASTA format for input into other anal-
ysis pipelines, such as motifs discovery tools (18). Genomic
tracks containing all peaks (from public data only or from
public and ENCODE merging) are available as tracks in
the UCSCGenome Browser for browsing and visual explo-
ration. We also developed a tool to allow the annotation
of genomic regions provided by users. Those regions are
compared against theReMap catalogue returning statistical
enrichments of TFs present within input regions compared
to random expectations. It thus becomes possible to study
bindings of specific TFs overrepresented in those regions.
DISCUSSION
In this study, we present an extensive catalogue of TFBS
forming complex architecture in the human genome re-
vealed by the integration of public ChIP-seq data. We ob-
serve that the regulatory binding landscape of our genome
is only starting to unravel as 8.8 million of non-redundant
sites are being detected with public non-ENCODEandEN-
CODE data sets involving a total of 237 TFs. This high
number of bound regions is concordant with the 8.4 million
distinct short sequence elements fromDNase I footprinting
found across 41 cell types (4). Indeed, one striking result
is that 794 megabases (Mb, 25.3%) of the genome is occu-
pied by our catalogue of boundDNA-binding proteins. The
latest ENCODE ChIP-seq analyses estimate 636 336 bind-
ing regions covering 355 Mb (11.3%) of the genome across
all cell types (4). We observe a similar number of 666 594
CRMs by integrating public non-ENCODE ChIP-seq data
only; however, this number increases up to 802 508 CRMs
when merging the ENCODE repertoire.
Our analyses provide two evidences. First, there is more
complexity in regulatory regions than initially thought. In-
deed, the number of binding sites in the genome does not
double, but increases by 63% (from 5.4 to 8.8 M) when
adding 105 TFs specific to ENCODE.However, the number
of detected TF DNA-bound regions does not seems to be
yet a finite number of regions in the human genome as the
CRMs number does not reach a plateau (Figure 3E). Inter-
estingly, compared to the amount of TFBS the number of
CRMs remains low, giving an opportunity to identify com-
plex occupancy regions defined as CRMs containing multi-
ple TFBS. Indeed, we observed CRMs with highly complex
TFs combination. Those large CRMs could be affiliated as
super-enhancers recently described to control cell identity
as they are associated with key genes controlling cell state
(6). Our results lay the groundwork for further global anno-
tation and fine dissection of super-enhancers in the genome.
Our catalogue provides a global view of all detected TF
binding in a wide variety of cellular context. In our study
we observe a high fraction of TF binding in promoters in
a multi-cellular context, as our catalogue aggregates mul-
tiple biological sources. At the level of histone modifica-
tions, Shen et al. (3) have found in mouse that the occu-
pancy of enhancers by H3K4me1 is still the most tissue-
specific, whereas they observe that H3K4me3 mark occu-
pies most RefSeq promoters in multiple tissues. Looking
at the co-binding patterns of TFs in human, Wang et al.
(42) have described cell-type-specific binding of sequence-
specific TF. They observed that genes specifically expressed
in a cell line are often associated with a greater occurrence
of nearby TF binding in that cell line. They also show a cor-
relation between the amount of TF binding in a given cell
line and their genes expression. Thus, high concentration of
observed binding sites potentially increase TF interactions,
as cell-type-specific interactions among TFs can play a crit-
ical role in different gene expression (50). Finally, variations
of the chromatin accessibility between cell types have to be
taken into account for downstream analyses (51). However,
our catalogue gives a first clue of genomic binding of 237
TFs in specific locations in the genome across multiple bio-
logical conditions.
One of the major advantages of this catalogue is the abil-
ity to compare occupancy maps across different data sets
for a single factor. This comparison of bound regions for
the same factor allows for direct evaluation of binding sites
(Figure 1A). While quality assessments and metric scores
of ChIP-seq data have been applied to select and evalu-
ate ChIP-seq data sets (10,52), the analysis of global inte-
gration of public ChIP-seq occupancy maps while includ-
ing ENCODE has not been studied in depth. Even with an
automated pipeline the heterogeneity of those public non-
ENCODE data sets necessitates a time-consuming man-
ual curation coupled with an understanding of the analyses
description provided. Also, the blind application of qual-
ity metrics without biological context should be taken with
cautions (10), hence, the benefit of annotating redundant
binding sites across multiple cell types and studies. In their
work Marinov et al. demonstrate that a mediocre ChIP-seq
data set can possibly receive a high QC score, or as opposite
have a low QC score for a good data set. However, our find-
ings from analysing 395 ChIP-seq data sets together with
data from ENCODE suggest that a global integration may
provide an overall landmark in the annotation of TF occu-
pancy maps in the human genome.
A logical application to this catalogue would be to in-
vestigate this new regulatory search space like exons-based
approaches in order to characterize the effect of SNPs on
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regulatory regions at a global scale (53,54). For instance, in
our study we validated the added genomic value of this cat-
alogue by interrogating our regulatory map to analyse VEL
in colorectal and breast cancer cell lines. We dissected those
VELs for specific enrichments of TFs giving new insights
into the possible implications of key regulators role in those
cancers.
Howmany of these regulatory regions havemultiple roles
under different cellular environments and how this cata-
logue can be classified between gene regulatory elements
and enhancers is only starting to unfold (6,55,56). However,
our catalogue is a multi-cell map currently limited to the
cell types and TFs stored in data warehouse. The integra-
tion of more ChIP-seq data may reveal other major occu-
pancy maps, complement current CRMs or affine CRMs
composition. How many of these detected regulatory ele-
ments contribute to gene expression is an open question. In-
deed, the next major step in the understanding of gene reg-
ulation will reveal physical and direct links between those
regulatory regions and their target genes, but more globally
between the landscape of bound elements and the rest of
our genome. Techniques, such as chromatin conformation
capture (3C, 4C, 5C) (57), Hi-C (58) andChIA-PET (59,60),
started to provide the first clues of those interactions. How-
ever, how much of those regions are truly functional is still
an open question.
In summary, we have shown that integration of pub-
lic non-ENCODE ChIP-seq data sets provide a large cat-
alogue of complex regulatory elements organized along
the genome. In combination with ENCODE, this regula-
tory map complement and complexify current findings. Al-
though new data sets are constantly added to repositories
we believe that this first large regulatory factor occupancy
resource may help in better understanding the regulation
processes in human.
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